SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    North Carolina Senate Passes Medical Cannabis Legalization Bill

    By

    North Carolina’s Senate has approved legislation aiming to legalize medical cannabis, putting the state a step closer to becoming the 39th to do so.

    On Thursday, the Senate voted by 33-9 to approve legislation that would enable patients with a ‘debilitating medical condition’ to access medical cannabis.

    It came just a day after the last-minute provision was added to a bill on Wednesday, aiming to further regulate hemp products with a THC content of less than 0.3%.

    The amendment was made in order to ‘get out in front’ of the upcoming federal reclassification of cannabis to a Schedule I substance, according to Republican Senator Danny Britt.

    Next, the bill will need to be approved a second time, before heading to the state House for a final vote.

    In July 2023, the House blocked a similar move to legalize medical cannabis, and it is so far unclear whether the bill is likely to suffer a similar fate this time around.

    Under the proposals, patients with a doctor’s recommendation could use cannabis to treat severe health conditions like cancer or epilepsy. The bill also introduces regulations for hemp products, including minimum age requirements for purchasing and licensing rules for businesses involved in manufacturing and sales.

    Patients could smoke or vape cannabis with a doctor’s recommendation specifying dosage and delivery method, requiring annual reevaluation to continue usage.

    The bill allows for the licensing of up to 10 medical cannabis suppliers, overseen by a newly established Medical Cannabis Production Commission. Rabon pointed out that obtaining medical cannabis will be more stringent than acquiring hemp products under this legislation.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free